(Leibniz Research Laboratories for Biotechnology and Artificial Organs, LEBAO) and Prof. Dr. Axel Haverich, both Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG). Further leaders [...] Gruh): Entwicklung eines Potency Assays für iPS-Zell-basierte Kardiomyozyten Teilprojekt 6 (MHH: Haverich, Sarikouch): Entwicklung eines Protokolls zur klinischen Anwendung autologer humaner iPS-Zell-basierter [...] Marketingstrategien unter Berücksichtigung ethischer und rechtlicher Fragen Teilprojekt C (MHH: Martin, Haverich): Koordination des iCARE-Verbundes Subprojects Subproject 1 (MHH: Cebotari, Martin; DPZ, ITEM):

che Allgemeine Zeitung at the Anzeiger Hochhaus on 14th September 2016, at which Prof. Dr. Axel Haverich (HTTG, MHH), Prof. Dr. Ulrich Martin (LEBAO), Prof. Dr. Michael Manns (Department of Gastroenterology

Skvorc, D., Gawol, A., Azizian, A., Wagner, S., Maier, L. S., Krause, A., Drager, G., Ochs, M., Haverich, A., Gruh, I.#, and Martin, U.#. 2013. Murine and human pluripotent stem cell-derived cardiac bodies

in childhood so that the circuits are separated," says HTTG Clinic Director Professor Dr. Axel Haverich. However, the incomplete heart still has a reduced pumping capacity. The biological heart prosthesis

multiple surgeries in childhood to separate the circuits," says HTTG Clinic Director Professor Axel Haverich, MD. The incomplete heart, however, continues to have a reduced pumping capacity. The biological

Schott S, Kreimann K, Doricic J , Leffler A, Tudorache I, Salman J, Natanov R, Ius F, Fegbeutel C, Haverich A, Lichtinghagen R, Chen R, Rong S, Haller H, Vijayan V, Gram M, Scheffner I , Gueler F, Gwinner [...] doi: 10.3390/biomedicines10051198 Doricic J , Greite R , Vijayan V, Immenschuh S, Leffler A, Ius F, Haverich A, Gottlieb J, Haller H, Scheffner I and Gwinner W . Kidney injury after lung transplantation: Long-term

J-R, Emmert MY, Mueller E, Kueest SM, Cohrs S, Schibli R, Kronen P, Hilbe M, Reinisch A, Strunk D, Haverich A, Hoerstrup S, Luescher TF, Kaufmann PA, Landmesser U*, Martin U*: Transplantation and tracking

d.ncbi.nlm.nih.gov/33141843 Szepes M, Melchert A, Dahlmann J, Hegermann J, Werlein C, Jonigk D, Haverich A, Martin U, Olmer R, Gruh I. Dual function of iPSC-derived pericyte-like cells in vascularization [...] Eur Heart J. 2020. https://pubmed.ncbi.nlm.nih.gov/32657324 Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk [...] Lingk A, Wendland M, Greten S, Schmitto JD, Ismail I, Warnecke G, Zywietz U, Chichkov B, Meissner J, Haverich A, Martin U, Brenner B, Zweigerdt R, Kraft T. Advanced single-cell mapping reveals that in hESC

nlm.nih.gov/34955331/ . Kamp JC, Neubert L, Stark H, Hinrichs JB, Boekhoff C, Seidel AD, Ius F, Haverich A, Gottlieb J, Welte T, Braubach P, Laenger F, Hoeper MM, Kuehnel MP, Jonigk DD. Comparative analysis [...] T, Mariani S, Bounader K, Boethig D, Schöde A, Homann K, Hanke JS, Napp LC, Merzah AS, Dogan G, Haverich A, Schmitto JD. Is there a sex gap in outcomes of comparable patients supported with left ventricular [...] L, Ackermann M, Stark H, Plucinski E, Shah HR, Janciauskiene S, Bergmann AK, Schmidt G, Welte T, Haverich A, Werlein C, Braubach P, Laenger F, Schwerk N, Olsson KM, Fuge J, Park D, Schupp JC, Hoeper MM

heart repair – with six partner institutions, coordinated by Prof. Dr. U. Martin and Prof. Dr. A. Haverich (LEBAO, HTTG , MHH ). The BMBF-funded project 3D-Heart-2B coordinated by Prof. Dr. Ina Gruh aims